Immunodiagnostics Market is estimated to be US$ 39.69 billion by 2030 with a CAGR of 7.50%

NEW YORK, Calif. - May 6, 2022 - PRLog -- mmunodiagnostics (https://www.prophecymarketinsights.com/market_insight/Immunodiagnostics-Market-4874) is a field of in vitro diagnostics that uses antigen antibody responses to diagnose disease. It is used to diagnose infectious infections as well as chronic diseases such as cancer and autoimmune disorders. It is used to treat cardiovascular diseases, infectious diseases, autoimmune disorders, endocrinology, and oncology, among other things. The human immune system is a complicated network of interconnected cells. Immunodiagnostics have advanced significantly, allowing for more accurate diagnosis of this complicated interacting network. The rise in the frequency and prevalence of infectious disorders (HIV, hepatitis, and other sexually transmitted infections), cardiovascular diseases, malignancies, and other chronic diseases has bolstered the immunodiagnostics industry. Furthermore, the expanding senior population, as well as changing lifestyle and demography, drive the market. The worldwide immunodiagnostics market is being driven by technological advancement and increased awareness.

Key Highlights:

• Roche Diagnostics will launch the cobas SARS-CoV-2 Variant Set 1 Test in March 2021 to assist in the monitoring of developing coronavirus mutations.

Key Market Insights from the report:

Global Immunodiagnostics Market accounted for US$ 19.30 billion in 2020 and is estimated to be US$ 39.69 billion by 2030 and is anticipated to register a CAGR of 7.50%.  The Global Immunodiagnostics Market report segments the market on the basis of type, technology, application and region.

Competitive Landscape & their strategies of Global Immunodiagnostics Market:

The key players operating in the Global Immunodiagnostics Market includes Abbott Laboratories, Immunodiagnostic Systems Holdings Plc (IDS), DiaSorin S.p.A., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Siemens AG, Sysmex Corporation, Danaher Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., and Arkray, Inc.